No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr13:50422200-50436600 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
2 |
chr13:50431000-50433000 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
3 |
chr13:50431200-50432400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
4 |
chr13:50431200-50433800 |
Enhancers |
NHLF |
lung
|
5 |
chr13:50431200-50434600 |
Enhancers |
HMEC |
breast
|
6 |
chr13:50431400-50432400 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
7 |
chr13:50431400-50432400 |
Flanking Active TSS |
HepG2 |
liver
|
8 |
chr13:50431400-50432800 |
Enhancers |
Pancreas |
Pancrea
|
9 |
chr13:50431400-50433600 |
Flanking Active TSS |
Liver |
Liver
|
10 |
chr13:50431400-50434000 |
Enhancers |
Hela-S3 |
cervix
|
11 |
chr13:50431400-50434000 |
Enhancers |
HSMM |
muscle
|
12 |
chr13:50431400-50434200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
13 |
chr13:50431400-50434200 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
14 |
chr13:50431600-50432400 |
Weak transcription |
Placenta |
Placenta
|
15 |
chr13:50431600-50432600 |
Enhancers |
NH-A |
brain
|
16 |
chr13:50431600-50433400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
17 |
chr13:50431600-50433400 |
Enhancers |
Osteobl |
bone
|
18 |
chr13:50431600-50434200 |
Enhancers |
NHDF-Ad |
bronchial
|
19 |
chr13:50431600-50434600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
20 |
chr13:50431800-50432200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
21 |
chr13:50431800-50433200 |
Active TSS |
A549 |
lung
|
22 |
chr13:50432000-50432200 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|